REG - Primary Health Props - Scrip dividend reference price

Primary Health PropertiesAnnouncement

21/01/2021 12:00

RNS Number : 4623M
  
Primary Health Properties PLC
  
21 January 2021
  
 

 
Primary Health Properties PLC
(the "Company")
 
Scrip Dividend Scheme
 
The Company announces that the scrip dividend reference price for the First Quarterly Interim Dividend in 2021 (the "Interim Dividend"), payable on 26 February 2021, is 148.52 pence.  
 
The reference price is the price at which ordinary shares of 12.5p each ("Ordinary shares") of Primary Health Properties PLC will be issued to shareholders who have elected to receive shares in lieu of cash dividends through participation in the Scrip Dividend Scheme and is the average of the closing middle market quotations of the Ordinary shares derived from the London Stock Exchange Daily Official List for the day on which the Ordinary shares were first quoted as ex-dividend (14 January 2021) and the four subsequent dealing days (being 15,18,19 and 20 January 2021).
 
Any shareholders entitled to the Interim Dividend who do not already participate in the Scrip Dividend Scheme (or whose mandates are not deemed valid and effective, as explained above) and wish to do so, may obtain a mandate form either by contacting the Company's Registrar, Equiniti, on 0871 384 2268, or by downloading from the Company's website www.phpgroup.co.uk/Investors, or from the National Storage Mechanism. This form must be completed and returned to Equiniti to arrive no later than the close of business on 5 February 2021 in order for it to be effective for the Interim Dividend.
 
 
Contacts:
 
Paul Wright, Company Secretary
Telephone: 0207 451 7057
 
Legal Entity Identifier: 213800Y5CJHXOATK7X11
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
DIVUARRRAUUAUAR